Next Article in Journal
Soft Sensor Development for Real-Time Process Monitoring of Multidimensional Fractionation in Tubular Centrifuges
Previous Article in Journal
Superparamagnetic ZnFe2O4 Nanoparticles-Reduced Graphene Oxide-Polyurethane Resin Based Nanocomposites for Electromagnetic Interference Shielding Application
Previous Article in Special Issue
Polyethylene Glycol Coated Magnetic Nanoparticles: Hybrid Nanofluid Formulation, Properties and Drug Delivery Prospects
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Multifunctional Magneto-Plasmonic Fe3O4/Au Nanocomposites: Approaching Magnetophoretically-Enhanced Photothermal Therapy

1
Chuiko Institute of Surface Chemistry, National Academy of Sciences of Ukraine, 03164 Kyiv, Ukraine
2
College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China
3
Institute of Physics, National Academy of Sciences of Ukraine, 03028 Kyiv, Ukraine
4
Department of Physics & Astronomy, University College London Healthcare Biomagnetic and Nanomaterials Laboratory, London W1S 4BS, UK
5
V. Lashkaryov Institute of Semiconductors Physics, National Academy of Sciences of Ukraine, 03028 Kyiv, Ukraine
6
Semiconductor Physics, Chemnitz University of Technology, 09107 Chemnitz, Germany
7
Helmholtz Zentrum München, Institute of Biological and Medical Imaging, 85764 Neuherberg, Germany
8
School of Medicine, Technical University of Munich, 80333 Munich, Germany
*
Authors to whom correspondence should be addressed.
Nanomaterials 2021, 11(5), 1113; https://doi.org/10.3390/nano11051113
Submission received: 16 March 2021 / Revised: 21 April 2021 / Accepted: 22 April 2021 / Published: 25 April 2021

Abstract

:
Magneto-plasmonic nanocomposites can possess properties inherent to both individual components (iron oxide and gold nanoparticles) and are reported to demonstrate high potential in targeted drug delivery and therapy. Herein, we report on Fe3O4/Au magneto-plasmonic nanocomposites (MPNC) synthesized with the use of amino acid tryptophan via chemical and photochemical reduction of Au ions in the presence of nanosized magnetite. The magnetic field (MF) induced aggregation was accompanied by an increase in the absorption in the near-infrared (NIR) spectral region, which was demonstrated to provide an enhanced photothermal (PT) effect under NIR laser irradiation (at 808 nm). A possibility for therapeutic application of the MPNC was illustrated using cancer cells in vitro. Cultured HeLa cells were treated by MPNC in the presence of MF and without it, following laser irradiation and imaging using confocal laser scanning microscopy. After scanning laser irradiation of the MPNC/MF treated cells, a formation and rise of photothermally-induced microbubbles on the cell surfaces was observed, leading to a damage of the cell membrane and cell destruction. We conclude that the synthesized magneto-plasmonic Fe3O4/Au nanosystems exhibit magnetic field-induced reversible aggregation accompanied by an increase in NIR absorption, allowing for an opportunity to magnetophoretically control and locally enhance a NIR light-induced thermal effect, which holds high promise for the application in photothermal therapy.

1. Introduction

Gold nanoparticles (including nanoshells, nanorods, nanostars, etc.) represent a well-known class of photoactive nanoagents that can be applied in photothermal therapy (PTT) of cancer and other diseases [1,2,3,4]. Due to the phenomenon of localized surface plasmon resonance (LSPR) [5], spherical gold nanoparticles (NPs) in colloidal suspensions display a specific red color that corresponds to a characteristic absorption band peaked at ~520–530 nm. The advantages of plasmonic gold nanospheres over anisotropic nanostructures comprise generally simple synthesis, narrow size distribution and, especially, higher thermodynamic stability [6]. Gold NPs-based phototherapeutic agents were demonstrated to produce efficient PTT effects both in vitro and in vivo [1,2,3,4]. The LSPR band position can be shifted upon association (aggregation) of gold NPs: It leads to the formation of a new absorption band at longer wavelengths as a result of electric dipole-dipole interaction and coupling between the plasmons of neighboring particles in the formed aggregates [7,8,9,10]. In turn, a shift of the absorption of the aggregated gold nanoparticles towards the near-infrared (NIR) region allows for utilization of NIR light (which is known to deeper penetrate biological tissues due to lesser absorption and scattering) for induction or enhancement of photothermal effects [11]. On the other hand, NIR plasmonic absorbance for photothermal therapy can be achieved by using anisotropic gold nanoparticles (e.g., nanorods, nanocages, nanoshells, nanostars, etc. [4,12,13], or hybrid (composite) nanostructures that comprise gold with other materials [14,15,16]. Due to higher intrinsic NIR absorbance and photothermal transfer ability of gold-based anisotropic nanoparticles, they showed promising preliminary results in PTT applications. However, they are relatively difficult to synthesize, can be contaminated with toxic surfactants used in their preparation (e.g., cetyltrimethylammonium bromide, CTAB) and are also relatively large in size (~over 50 nm), which can promote an efficient capture by the reticuloendothelial system (RES), limiting systemic circulation time, tumor targeting, efficient endocytosis into cancerous cells and posing potential clearance problems when clinically tried [11,17,18]. Recent reports suggest that these disadvantages of PTT with complex anisotropic gold nanostructures can be overcome through an employment of the gold NPs with aggregation triggered by tumor-specific stimuli (e.g., pH), thus inducing NIR absorbance in situ in the targeted area (i.e., malignant tissue) and providing significant improvement of PTT of cancer [19,20].
Currently, there is a growing interest towards nanocomposites of iron oxide (Fe3O4) and gold (Au), which combine magnetic and optical (plasmonic) properties inherent to both individual components; such magneto-plasmonic nanocomposites manifest high potential for targeted drug delivery and therapeutic applications [21,22]. In the case of complex magneto-plasmonic nanosystems, a magnetic field can be applied for their targeted delivery to cancer cells and increased uptake, allowing for enhanced photothermal effect through irradiation in the plasmonic absorption band, followed by efficient PTT demonstrated in vitro and in vivo [23,24,25]. On the other hand, the application of a magnetic field can induce interaction or aggregation of magneto-plasmonic nanoparticles that may cause changes in their optical properties [26,27]. A number of studies reported magneto-plasmonic nanosystems with magnetically induced aggregation producing change of their optical properties (e.g., enhancing the surface-enhanced Raman spectroscopy (SERS) signal [28,29,30,31]. However, no study devoted to a magnetic field induced shift of the plasmonic absorbance of magneto-plasmonic nanostructures into NIR region could be found. Moreover, to the best of our knowledge, the use of a magnetic field to generate NIR absorption of magneto-plasmonic nanostructures, resulting in a boost in efficiency of NIR induced photothermal effect/PTT, have not been reported before.
In this work, we report the preparation of Fe3O4/Au magneto-plasmonic nanocomposites (MPNC) containing nanosized magnetite and gold constituents. The size and morphology of Fe3O4/Au in colloids with various gold content were characterized by transmission electron microscopy and dynamic light scattering methods, the optical properties were studied by UV–VIS spectroscopy; X-ray photoelectron spectroscopy was applied to assess the elemental composition. Aqueous suspensions of MPNC manifested LSPR absorption band with peak position tunable by the composition of the nanocomposites (i.e., Fe3O4/Au ratio). Moreover, the absorption of MPNC demonstrated a shift in NIR spectral region and was found to rise due to the reversible aggregation of nanocomposites under an external magnetic field. Even more, a magnetic field induced increase in NIR absorption was shown to correlate with an increase in photothermal effect induced in magnetic field treated MPNC colloids by irradiation with a NIR (808 nm) laser diode. The possibility for therapeutic application of the magnetic field-induced increase in the NIR absorption, which resulted in an enhanced photothermal effect under laser irradiation, was also demonstrated using cancer cells in vitro. Cell membrane damage and cell destruction, which were revealed using confocal laser scanning microscopy, evidently originated from the formation of microbubbles on the cell surface due to the photothermal effect caused by the laser scanning irradiation of MPNC. It should also be noted that our MPNC were found to be core-satellite structures, which may have an advantage of higher light-to-heat conversion efficiency, as it was recently shown [32]. Thus, the synthesized magneto-plasmonic Fe3O4/Au nanosystems are highly promising for the magnetophoretically-controlled photothermal therapy. The possibility to enhance NIR absorption on demand in situ, in a targeted diseased tissue, to boost the NIR induced photothermal effect can be significant for the field of phototherapy of cancer and other diseases.

2. Materials and Methods

Chemicals. Iron(II) chloride tetrahydrate (FeCl2∙4H2O, Sigma-Aldrich, Gillingham, UK), iron(III) chloride hexahydrate (FeCl3∙6H2O, Sigma-Aldrich, Gillingham, UK), ammonium hydroxide solution (NH4OH, Sigma-Aldrich, Gillingham, UK), tryptophan (C11H12N2O2, SC12-20120713, Xintai Jiahe International Co., Ltd., Shandong Province, China), sodium hydroxide (NaOH, Merck, Darmstadt, Germany), tetrachloroauric acid (HAuCl4, Merck, Darmstadt, Germany), pluronic F68 ((C3H6O·C2H4O)x, Aldrich, Milwaukee, W, USA), sodium citrate (Na3C6H5O7, Acros, Renningen, Germany).

2.1. Synthesis of Fe3O4/Au Nanocomposites

Two methods, chemical and photochemical, were used to obtain plasmonic nanosized gold in the presence of nanosized magnetite, pre-prepared according to [33]. In particular, Fe3O4 nanoparticles were synthesized by coprecipitation of ferric and ferrous chloride salts in a 1:2 molar ratio with ammonium hydroxide under an inert atmosphere at 70 °C. In a simplified manner, the reaction mechanism can be presented as: Fe2+ + 2Fe3+ + 8OH ⇆ Fe(OH)2 + 2Fe(OH)3→Fe3O4↓ + 4H2O. Briefly, 300 mL of 0.38 M ammonium hydroxide solution used as a precipitation agent was mixed with 30 mL of FeCl2·4H2O (0.02 M) and FeCl3·6H2O (0.04 M) at a continuous stirring speed of 700 rpm. The obtained nanoparticles were washed by centrifugation (7500 rpm, 10 min, 3 times, 20 mL DIH2O) and redispersed in DIH2O leading to neutral pH. The obtained powder was stabilized by sodium oleate.
Colloidal Fe3O4/Au nanocomposites were prepared in an aqueous solution of tryptophan (Trp) with initial alkaline medium (pH = 10) reached by a 1 N solution of sodium hydroxide using the following concentrations of reagents: CTrp = 2 × 10−4 M, C Fe3O4 = 5 × 10−5 M; the synthesis was performed at different Au concentration, CAu varied from 1 × 10−4 to 3 × 10−4 M. Fe3O4 was injected in the solution before tetrachloroauric acid.
While the chemical reduction of Au ions by tryptophan proceeded at boiling temperature, the photochemical process occurred at room temperature under UV light irradiation during 5 h using a light emission diode UV-C LED (LGInnotek) with a wavelength of λ = 278 nm and an output optical power density of P = 3.0 ± 0.1 mW/cm2 as a light source in the 40 mL quartz glass.
The Fe3O4/Au nanocomposites formed in the colloid were aggregated in a certain way with nitric acid, accumulated by a commercial NdFeB magnet and washed with distilled water twice. Final Fe3O4/Au suspensions were dissolved at CAu = 3 × 10−3 M in polymer pluronic F68 and sodium citrate for further application.

2.2. Characterization of Fe3O4/Au Nanocomposites

Optical properties. The absorption spectra of the MPNC colloids were recorded in a 1 cm quartz cell using a spectrophotometer Lambda 35 (Perkin-Elmer, Waltham, MA, USA).
Size and morphology. Gold and Fe3O4/Au NPs were characterized by transmission electron microscopy (TEM) using a JEOL-1200 EX (JEOL, Tokyo, Japan) at an accelerating voltage of 120 kV. The NP dispersions were diluted in DI water, dropped onto a carbon-coated copper grid, and dried at room temperature. Particle size analysis was performed from TEM images manually via the image analysis software ImageJ. Particle size distributions (presented in insets for corresponding TEM image) have the following notations: dTEM is the average diameter, δd is the standard deviation, and n is the number of particles counted to obtain the particle size distribution.
Size and zeta potential distribution. Distribution of MPNC size and zeta potential was assessed by a dynamic light scattering (DLS) method using laser correlation spectrometer Zeta Sizer Nano S (Malvern Panalytical Ltd, Malvern, UK) equipped with a correlator (multi-computing correlator type 7032 CE). The helium-neon laser LGN–111 was used with the output power of 25 mW and wavelength of 633 nm to irradiate the suspension. The registration and statistical processing of the scattered laser light at 173° from the suspension were performed three times during 120 s at 25 °C. The resulting autocorrelation function was treated with standard computer programs PCS–Size mode v.1.61.
X-ray photoelectron spectroscopy. X-ray photoelectron spectroscopy (XPS) measurements were performed with an ESCALAB 250Xi X-ray photoelectron spectrometer microprobe (Thermo Scientific, Waltham, MA, USA) equipped with a monochromatic Al Kα (hν = 1486.68 eV) X-ray source. A pass energy of 200 eV was used for survey spectra and 20 eV for high-resolution core-level spectra (providing a spectral resolution of 0.5 eV). Spectra deconvolution and quantification were performed using the Avantage Data System (Thermo Scientific). The linearity of the energy scale was calibrated by the positions of the Fermi edge at 0.00 ± 0.05 eV, Au4f7/2 at 83.95 eV, Ag3d5/2 at 368.20 eV, and Cu2p3/2 at 932.60 eV measured on in situ cleaned metal surfaces. To prevent charging, the NCs samples were measured employing the built-in charge compensation system. Finally, the spectra were corrected to C 1s sp3 peak at 284.8 eV as the common internal standard for BE calibration [34].
Photothermal effect. The PT effect produced by MPNC was assessed using a laser diode emitting at 808 nm with an irradiation power density of 70 mW/cm2. During the experiment, a thermocouple connected to a multimeter for temperature measurement was dipped into the cuvette with the irradiated MPNC suspension.
Optical imaging. Confocal laser scanning microscopy imaging in fluorescence, reflection and transmission channels was performed using a home-built confocal microscope based on a commercial Olympus IX83 microscope. Fluorescence and reflection imaging were performed with 485 nm laser (LDH-D-C-485, PicoQuant, Berlin, Germany) driven by a corresponding driver (PDL 800-D dual mode, PicoQuant, Berlin, Germany). For heating, a pulsed laser emitting at 593 nm emission wavelength (Katana 06-HP, OneFive, Zürich, Switzerland) was utilized. Both laser beams were combined using a dichoric beam splitter (ZT594DCRB, Chroma Technology Corp, Bellows Falls, VT, USA), collimated and expanded using telescopes in order to fill the back aperture of the UPLSAPO60XW 1.2 NA water immersion objective (Olympus, Tokyo, Japan). The fluorescence from the sample was separated from the excitation beams using a combination of a dichroic mirror (ZT488DCRB) and a bandpass emission filter (ET535/70 m), both from Chroma Technology Corp, USA. After spatial filtering with a 50 µm pinhole (MPH16, Thorlabs, Dachau, Germany) the fluorescence was detected using an avalanche photodiode (SPCM-AQRH-13, Excelitas, Waltham, MA, USA). The reflected light was separated from the illumination light using a 2 µm thin pellicle beamsplitter (BP108, Thorlabs, Dachau, Germany) and redirected towards a PMT module (H10723-01, Hamamatsu Photonics, Hamamatsu City, Japan). The voltage signal from the PMT was digitalized by a DAQ card (PCIe-6353, National Instruments, Austin, TX, USA) and plotted using home-written scripts in MATLAB (Mathworks, Natick, MA, USA), which also controlled the scanning mirrors (dynAXIS 421, ScanLab GmbH, Munich, Germany) scanning the focal spot to image the sample area.
Optical transmission images were acquired using a white light LED lamp and a CCD camera (DMK 23U274, The Imaging Source, Bremen, Germany) coupled to a side port of the microscope.
Cell culture. To study the photothermal effect of the prepared Fe3O4/Au nanocomposites on cancer cells in vitro, the ovarian cancer cell line (HeLa) was used. For better visualization of the cell cytoskeleton in fluorescence imaging, the keratin protein of HeLa cells, which is an intermediate filament protein that forms cytoskeletal filament networks in epithelial cells, was fused with a GFP-like fluorescent protein rsEGFP2 [35]. HeLa cells seeded in 35 mm cell dishes (P35G-0.170-14-C, Mattek, Ashland, MA, USA) were maintained in a DMEM medium with 10% fetal bovine serum (FBS), 100 U/mL penicillin/streptomycin solution and 1 mM sodium pyruvate. Cells were gently rinsed with the pre-warmed to 37 °C buffer (Gibco™ PBS pH 7.4, ThermoFisher, Schwerte, Germany) prior treatment with the MPNC.
Demonstration of photothermal effect in vitro. HeLa cells in a dish, that was placed in a sample holder of the microscope, were incubated with MPNC at CAu = 1.25 × 10−4 M under an applied magnetic field for 100 min. Next, HeLa cells treated with Fe3O4/Au nanocomposites were imaged, with an imaging area of 80 μm × 120 μm. MPNC localization and with cell morphology were monitored in time using transmission, reflection and fluorescence channels of the microscope.
For the induction of bubbles formation, laser irradiation at a wavelength of 593 nm was applied with the following parameters: pulse energy 5 nJ, pulse duration 1 ns, repetition rate 20 MHz, 4 J/cm2.

3. Results and Discussion

3.1. Characterization of Fe3O4/Au Nanocomposites and Their Optical Properties

MPNC presented in this work comprised Fe3O4 and Au constituents. They were prepared via reduction of Au(III) from HAuCl4 by amino acid tryptophan (according to a previously developed procedure for the preparation of plasmonic metal colloids with the use of tryptophan [36]) in the presence of pre-formed nanosized magnetite. This approach allowed for obtaining of colloidal Fe3O4/Au MPNC that exhibit magnetic and optical (plasmonic) properties inherent to both individual components. Optical properties (Figure 1a–c) and stability of nanocomposites (Figure 1d) were found to significantly depend on the metal content.
The synthesized Fe3O4/Au colloids can be efficiently separated into magnetic and non-magnetic fractions by applying a magnet for each sample (Figure 1d). Hence, the optical absorption spectra of the prepared colloids (Figure 1a) were the sum of those of both magnetic (Figure 1b) and non-magnetic (Figure 1c) components. The LSPR bands of both fractions changed with an increase in gold content in the same manner: increased intensity—shifted maximum—decreased intensity.
Initial Fe3O4/Au colloids. The intensity of the plasmon absorption band of nanosized gold increased with an increase in metal content from 1 × 10−4 to 2 × 10−4 M, which was accompanied with a shift of the LSPR peak from 524 to 532 nm. When a higher concentration of 2.5 × 10−4 M was used, the LSPR band maximum drastically shifted to ~567 nm. Further increase of the gold content to 3 × 10−4 M caused a shift of the LSPR peak to 619 nm, with a concomitant broadening and decrease in plasmon band intensity (Figure 1a).
Non-magnetic component. In the separated non-magnetic fraction of MPNC (i.e., gold NPs), the intensity of the LSPR band increased with an increase in CAu from 1 × 10−4 to 2 × 10−4 M, simultaneously with a shift of the band maximum from 527 to 532 nm (which is typical for the Au/Trp system (data not shown). Further increase in the gold content up to 2.5 × 10−4 M caused an aggregation of the particles reflected in the low intense and broad plasmon band with λmax = 546 nm in the absorption spectrum. No formation of the individual gold NPs was observed in the Fe3O4/Au system with CAu of 3 × 10−4 M.
Magnetic component. The plasmon absorption band of Au in the magnetic Fe3O4/Au component initially appeared as a small shoulder in the absorption spectrum and then rose as a well-shaped band with maximum at 525 nm at CAu = 2 × 10−4 M. Similarly, to absorption spectrum of gold NPs at CAu = 2.5 × 10−4 M, the plasmon band of the magnetic Fe3O4/Au component was shifted to 560 nm, but exhibited much higher intensity, with significant absorption in the region of longer wavelengths. Further increase of the gold content caused total aggregation of the particles and the colloid became unstable. Nevertheless, even at CAu = 3 × 10−4 M, MPNC still possess a distinct plasmon band with a maximum at 619 nm (Figure 1c).
Thus, the evolution of the optical absorption spectra has the same tendency for both magnetic and non-magnetic fractions. The sharp shift of the plasmon band position and further decreased of its intensity can be attributed to the plasmon coupling [7,8,9,10] caused by interaction (or aggregation) of gold NPs as shown below.
As it follows from the TEM results, nanoparticles in all obtained Fe3O4/Au systems were mostly spherical with an average size around 10 nm (Figure 1e). For the subsequent samples prepared with CAu = 2 × 10−4 M and CAu = 2.5 × 10−4 M the nanoparticle diameter was found to be d = 8.9 ± 1.4 nm and d = 10.6 ± 2.7 nm, correspondingly. Thus, the shift of the LSPR band maximum of 35 nm, as expected, is not associated with significant particle growth, but rather with the aggregation of the nanoparticles, as suggested by TEM data (Figure 1e).
X-ray photoelectron spectroscopy (XPS) was applied to reveal the composition in of Fe3O4/Au magnetic components in a series of MPNC colloids. In the spectrum of a control sample of pure magnetite NPs deposited on a Si/SiO2 substrate (Figure 2a), the O 1s peak of the Fe3O4 (BE = 529.8 eV) was well distinguished from the SiO2 peak (BE = 532.6 eV) and allowed the Fe:O ratio to be calculated precisely (2%). It amounts to 43:57, i.e., with a good precision coincides with the stoichiometry of Fe3O4. The spectral line shape of the Fe 2p in a sample prepared with CAu = 1 × 10−4 M indicates the initial Fe3O4 oxide in Fe3O4/Au (Figure 2b) (direct evaluation of the Fe:O ratio for these samples cannot be performed with sufficient accuracy because of the overlap between oxygen signals from amino acid and SiO2 surface of the substrate).
The Au:Fe ratio in the nanocomposites (calculated from the ratio of the corresponding XPS peaks intensities using Avantage software) increased with an increase in Au concentration. The evolution of the absolute and relative intensities of Au 4f and Fe 2p peaks within the series (Figure 2c,d, Table 1) confirms the formation and gradual growth of gold shell on the surface of the magnetite particles. Similarly, to UV–VIS absorption spectra, a drastic difference in XPS spectra between systems with CAu = 2 × 10−4 M and CAu = 2.5 × 10−4 M was noticed. The Au:Fe ratio in the surface layer of Fe3O4/Au is the same for the two higher concentrations, thus a saturation of magnetite surface with gold NPs appears to occur.
As Trp is known to absorb light in the UV region, UV light can be used for the activation of the redox reaction between the metal cation (or complex anion [AuCl4]) and Trp) It means that not only chemical method, but also photochemical one can be utilized for the Trp-induced preparation of M PNCs. When the chemical method is used, such experimental parameters as initial concentrations, ratio of the reagents and temperature of the reaction can be varied. In the case of the photochemical method, parameters like the irradiation power density and time can be additionally established to control the morphology of plasmonic nanoparticles [37,38].
For colloids of Fe3O4/Au nanocomposites obtained photochemically, we observed similar changes in the optical properties as for the chemically obtained series, but photochemically obtained colloids were overall more stable. The rate of formation of gold NPs under UV irradiation without heating was much slower, as the mechanism of particle growth was apparently affected. This approach contributed to the formation of structures of particles through the amino acid cross-linking.
The magnetic component both in the photochemically and chemically prepared samples were separated from colloids using a magnet and analyzed with the dynamic light scattering. According to the DLS data, the average hydrodynamic diameter of magnetite alone was around 45 nm, while Fe3O4/Au nanocomposites with gold content of 1 × 10−4–2 × 10−4 M were 10–20 nm larger, which corresponded to the size of individual gold NPs (Figure 3a). According to TEM measurements (Figure 3b), the average sizes of gold NPs in the non-magnetic component were of d = 9.1 ± 1.2 nm (1 × 10−4 M), 8.7 ± 1.4 (1.5 × 10−4 M), 10.6 ± 2.8 (2 × 10−4 M).
Further increase in the Au concentration resulted in an increase of the polydispersity index (PDI) for nanocomposites. Specifically, PDI magnitudes were 0.16 for the magnetite sample, 0.18–0.19—for Fe3O4/Au samples with 1 × 10−4…2 × 10−4 M, 0.28—for 2.25 × 10−4 M, and 0.39 corresponded to 2.5 × 10−4 M. Despite this, the average sizes of gold NPs according to TEM measurements were found to remain roughly around 10 nm (d = 8.9 ± 1.5 (2.25 × 10−4 M), 9.5 ± 2.4 (2.5 × 10−4 M), similarly to the previous series with the same gold content.
The intensity of the LSPR band of Au in photochemically prepared colloids increased with the increase in metal content in the whole range from 1 × 10−4 to 2.5 × 10−4 M with the position of the band maxima shifted from 520 to 533 nm. At the highest concentration of Au (2.5 × 10−4 M), the plasmonic band became broader with increased absorption in the region of longer wavelengths (Figure 4).
The LSPR absorption bands of Au in the magnetic Fe3O4/Au component appeared as a shoulder, forming a band maximum at 535 nm at the highest concentration of Au of CAu = 2.5 × 10−4 M.
Based on the data obtained by optical spectroscopy, XPS, TEM and DLS, we propose the structure of magneto-plasmonic nanosystems as nanocomposites with an inhomogeneous gold shell composed of individual NPs attached to the magnetite surface (Figure 5a). According to the classification of magneto-plasmonic nanostructures in [21], these are core-satellite structures. It is important to note that core-satellite gold nanostructures have been recently shown to have higher plasmonic heating efficiency [32], which is beneficial for PTT application.
As the charge of nanoparticles is the key point for the formation of nanocomposite structures, an acid (e.g., nitric acid) can be used to reduce the negative charge of individual gold NPs and stimulate their assembling on the surface of magnetite. In such a way, the gold content and Au/Fe3O4 ratio in colloids can be controlled, all remaining gold NPs in the non-magnetic fraction can finally be attached to the surface of the magnetic component.
It should be noted that for both studied series of samples, an increase in gold content (from HAuCl4 chloroauric acid used in the synthesis) is accompanied by a simultaneous increase in acid content. As a result, excessive protons compensate the negative charge of gold NPs formed in the alkaline medium, causing their aggregation. At the same time, the zeta potential values for chemically and photochemically prepared Fe3O4/Au samples (CAu = 2.5 × 10−4 M) were found to be −22.2 mV and −31.2 mV, correspondingly. To assess the effect of further acid addition, a drop of nitric acid (C = 0.001 N) was added to both chemically and photochemically prepared colloids. Upon the addition, zeta potential of MPNC was changing –from −22.2 to −6 mV and from −31.2 to −14 mV for the chemically and photochemically obtained Fe3O4/Au samples, respectively (CAu = 2.5 × 10−4 M). Such a decrease in zeta potential allowed for the stronger interaction of magneto-plasmonic and individual plasmonic particles, which can lead to stronger aggregation and formation of larger assemblies.
The size of assemblies in chemically prepared samples was found to be up to 500 nm, according to DLS results (Table 2, Figure 6). In the case of an aggregated MPNC (CAu = 2.5 × 10−4 M), there was a small fraction of assemblies with sizes of 1–3 μm.
The associates of photochemically synthesized MPNC were several times larger than those in case of chemically synthesized ones (average diameter of 2–4 μm versus 400–1000 nm, correspondingly). This can be advantageous for further activation of the Au-associated photothermal effect [26].
The normalized UV–VIS spectra of the colloidal systems after acid addition are shown in Figure 7a (dotted curves). All spectra contained Au plasmonic bands with maxima shifted to the long wavelength region in comparison with those in the initial colloids. The shift was about 17–18 nm for the photochemically prepared samples and 20–35 for the chemically prepared samples (Table 2). All photochemically obtained MPNC had a pronounced NIR absorption, while for chemically obtained systems a pronounced NIR absorption could be noticed only for samples with the highest content of gold.
The magnetic field induced the aggregation of MPNC (as shown in Figure 5c), which resulted in a significant change in absorption. The normalized spectra are shown on Figure 7a (solid curves). The rise of absorption intensity occurred in a broad NIR spectral range without a pronounced peak. This can be explained by a variety of the Au nanocomposites formed, interaction of nanoparticles of different sizes, and formation of assemblies of different number of nanocomposites. For the chemically obtained sample with maximum gold content, the absorption intensity increase in NIR region (at ~800–900 nm) was about 10–20%, while for all photochemically-obtained MPNC it was as high as 40–60%.
Comparing the two series with a similar content of gold, one can conclude that the photochemical method is advantageous for the preparation of Fe3O4/Au MPNC with the most pronounced reversible optical changes in the NIR region.
Based on the obtained results, the photochemical method and gold content of CAu = 2.5 × 10−4 M was chosen as the dynamic MPNC for further application as PTT agent, as there was the most advantageous combination the size of formed assemblies and increase of intensity in the NIR spectral region. Nanosized Fe3O4/Au composites were collected around the pole of the magnet from a volume of 2 mL with CAu = 2.5 × 10−3 M during five minutes for both systems. After washing, such MPNC can be easily redispersed in water using commonly used stabilizers, pluronic F68 or– sodium citrate (Figure 5c).

3.2. Photothermal Effect of Fe3O4/Au Nanocomposites

An irradiation by the laser diode at 808 nm was found to result in the increase in the temperature of the MPNC suspensions (i.e., photothermal effect). Figure 7b shows temperature kinetics for the MPNC suspensions [CAu = 2.5 × 10−4 M, prepared by the chemical (top) and photochemical (bottom) methods] under NIR (808 nm) laser irradiation with power density of 70 mW/cm2. It should be noted that the temperature of MPNC suspensions raised higher in the presence of MF (solid curves in Figure 7b) than without it (dotted curves) and there is a correlation between MF induced increase in NIR absorption (Figure 7a) and temperature kinetics in the irradiated MPNC suspension (Figure 7b).
The interaction of magneto-plasmonic Fe3O4/Au nanocomposites with HeLa cells was studied using confocal laser scanning microscopy in transmission, reflection and fluorescence channels. The Fe3O4/Au nanocomposites were added to HeLa cells in a dish that was placed in a microscope sample holder with magnet and incubated for 2 h (Figure 8a,b). The cells threated with MPNC were imaged in time using different confocal microscopy modes that provided a complementary information about processes in the cells/MPNC system.
As it is shown in Figure 5c and Figure 8c,d, Fe3O4/Au nanocomposites move under applied magnetic field. Similarly, MPNC move through the cell medium in the cell dish, being dragged by magnetic field (Figure 8e). Such a behavior of magnetic nanoparticles in cell dish treated with external magnet was previously reported [39]. At the same time, MPNC were found to accumulate on the surface of HeLa cells and remain in the imaged area (Figure 8e, green circles). Moreover, while some MPNC were observed to change their location in time, others did not move, suggesting stronger association with cell surface or cellular uptake.
To assess the photothermal effect of Fe3O4/Au nanocomposites in vitro, treated HeLa cells were irradiated with a 593 nm laser. Laser scanning was performed in the same area as for acquisition of the fluorescence or reflection images, which was done using a lower power 485 nm laser. The laser wavelength of 593 nm was closer to the plasmon resonance peak, causing the MPNC to easily absorb the irradiation energy.
Obvious changes were observed in cells after irradiation and associated photothermal effect. Instead of the assemblies of nanoparticles on the cell surfaces, which were clearly identified in reflection and transmission modes (Figure 9c,e), the irradiation induced microbubbles on the cell surface (Figure 9b,d,f) through rearrangement of keratin-GFP proteins from fibril structures, typical for keratin filaments, to uniform thin layers of the protein on a rim of microbubbles formed.
A similar microbubble formation was shown for NIR light irradiated epithelial cells derived from cancerous lung tissue in the presence of gold NPs and 4T1 cell derived solid breast cancer tumors [40,41]. A similar effect was also shown in [26], where phospholipid-based nanomicelles comprising gold nanorods and Fe3O4 nanoparticles were described. After cellular uptake of the magneto-plasmonic formulation enhanced by the external magnetic field, the laser irradiation at the wavelength of the gold nanorod absorption peak was performed and microbubbles were efficiently generated within cancer cells, causing cell destruction. It is worth, however, noting that no magnetic field induced change in NIR absorption was revealed for this magneto-plasmonic nanoformulation [26].
The irradiation/magnetic field induced cavitation regions evidenced the photothermal effect of synthesized magneto-plasmonic nanocomposites causing cytoskeleton and cell membrane damage, which can further cause cell death [26]. The size of bubbles was found to correlate with the size of the irradiated MPNC assemblies: The larger assembly was, the bigger bubble appeared. Microbubbles generated by nanosecond laser pulses were long lived, which allowed us to visualize them in HeLa cells suspension 20 min and more after irradiation. It should be noted that even just cell surface attached but not completely cell-internalized MPNC caused cell damage through a membrane destruction. A rapid magnetophoretic response of the developed MPNC can also allow for their use for targeted drug delivery induced by an applied magnetic field.

4. Conclusions

In summary, we developed Fe3O4/Au magneto-plasmonic nanocomposites with core-satellites structure using tryptophan for metal ion reduction. Owing to the surface plasmon resonance of Au counterparts, the MPNC exhibit well-shaped absorption band in the visible spectral region (540–600 nm) in MPNC. At the same time, because of the presence of Fe3O4 constituent MPNC can be magnetophoretically-controlled and concentrated using the external magnetic field. A magnetically-induced formation of the MPNC aggregates leads to an increase in optical absorption in NIR spectral rage (800–1000 nm), which can be eliminated by removing the magnetic field. The photochemical method of Fe3O4/Au MPNC preparation is found to be beneficial for the magnitude of the reversible (induced by presence of magnetic field) optical changes in the NIR region. The in situ magnetically induced aggregation of MPNC, which is accompanied by an increase in NIR absorption, suggests an approach to the magnetic field enhanced NIR-activated photothermal therapy of cancer and other diseases, as it was illustrated by the magnetic field enhanced photothermal effect in MPNC colloids. Furthermore, the magnetic field-induced concentration of MPNC on the surface of cultured cancer cells, followed by irradiation of the cells with scanning laser, led to the pronounced photothermal effect, which caused microbubble formation and membrane damage in the cancer cells. Thus, the synthesized magneto-plasmonic Fe3O4/Au nanocomposites demonstrate high potential towards magnetophoretically-controlled photothermal therapy. An ability to increase NIR absorption in situ on demand in a targeted diseased tissue for the enhanced photothermal effect can be of importance for the field of phototherapy of cancer and other diseases. A significance of the proposed approach will be further revealed using small animal model of cancer.

Author Contributions

I.M.—development of the idea, optical absorption and DLS measurements, optical imaging, data analysis, writing—original draft, funding acquisition, supervision; N.V.—synthesis of magneto-plasmonic Fe3O4/Au nanocomposites, optical absorption, DLS measurements; A.K.—development of equipment for photochemical synthesis, data analysis, writing—review and editing; L.S.—synthesis of Fe3O4 nanoparticles, TEM measurements, data analysis, writing—review and editing; O.C.—TEM measurements, data analysis, writing—review and editing.; V.N.—providing support for optical imaging; A.C.—optical microscopy imaging and data analysis, writing—review and editing; V.D.—XPS measurements and data analysis; D.R.T.Z.—XPS data analysis, writing—review and editing; T.Y.O.—conceiving the idea; data analysis; funding acquisition, writing—review and editing, supervision. All authors have read and agreed to the published version of the manuscript.

Funding

This work was partially supported by the National Academy of Sciences of Ukraine (grant on Research Laboratory for Young Scientists 29/2018–2019) and by the National Natural Science Foundation of China (grant 61875135). VD acknowledges Visiting Researcher Program of TU Chemnitz for support of his research at TU Chemnitz.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Acknowledgments

We acknowledge Yu-Shan Huang for assistance with preparation of the samples for optical microscopy studies, Kanuj Mishra and Andre-Christian Stiel for providing us with cultured cells. We thank S. Kolotilov for help with the DLS study.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Hwang, S.; Nam, J.; Jung, S.; Song, J.; Doh, H.; Kim, S. Gold nanoparticle-mediated photothermal therapy: Current status and future perspective. Nanomedicine 2014, 9, 2003–2022. [Google Scholar] [CrossRef] [PubMed]
  2. Yang, W.; Liang, H.; Ma, S.; Wang, D.; Huang, J. Gold nanoparticle based photothermal therapy: Development and application for effective cancer treatment. Sustain. Mater. Technol. 2019, 22, e00109. [Google Scholar] [CrossRef]
  3. Vines, J.B.; Yoon, J.-H.; Ryu, N.-E.; Lim, D.-J.; Park, H. Gold Nanoparticles for Photothermal Cancer Therapy. Front. Chem. 2019, 7, 167. [Google Scholar] [CrossRef] [Green Version]
  4. Huang, X.; Jain, P.K.; El-Sayed, I.H.; El-Sayed, M.A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 2007, 23, 217–228. [Google Scholar] [CrossRef]
  5. Pluchery, O. Chapter 3. Optical Properties of Gold Nanoparticles. In Gold Nanoparticles for Physics, Chemistry, and Biology; Louis, C., Pluchery, O., Eds.; Imperial College Press: London, UK, 2012. [Google Scholar]
  6. Taylor, A.B.; Siddiquee, A.M.; Chon, J.W.M. Below Melting Point Photothermal Reshaping of Single Gold Nanorods Driven by Surface Diffusion. ACS Nano 2014, 8, 12071–12079. [Google Scholar] [CrossRef]
  7. Jain, P.K.; El-Sayed, M.A. Plasmonic coupling in noble metal nanostructures. Chem. Phys. Lett. 2010, 487, 153–164. [Google Scholar] [CrossRef]
  8. Westcott, S.L.; Oldenburg, S.J.; Lee, T.R.; Halas, N.J. Construction of simple gold nanoparticle aggregates with controlled plasmon–plasmon interactions. Chem. Phys. Lett. 1999, 300, 651–655. [Google Scholar] [CrossRef]
  9. Thanh, N.T.K.; Rosenzweig, Z. Development of an Aggregation-Based Immunoassay for Anti-Protein A Using Gold Nanoparticles. Anal. Chem. 2002, 74, 1624–1628. [Google Scholar] [CrossRef]
  10. Yang, Y.; Matsubara, S.; Nogami, M.; Shi, J. Controlling the aggregation behavior of gold nanoparticles. Mater. Sci. Eng. B 2007, 140, 172–176. [Google Scholar] [CrossRef]
  11. Nam, J.; Won, N.; Jin, H.; Chung, H.; Kim, S. pH-Induced Aggregation of Gold Nanoparticles for Photothermal Cancer Therapy. J. Am. Chem. Soc. 2009, 131, 13639–13645. [Google Scholar] [CrossRef]
  12. Chen, J.; Glaus, C.; Laforest, R.; Zhang, Q.; Yang, M.; Gidding, M.; Welch, M.J.; Xia, Y. Gold Nanocages as Photothermal Transducers for Cancer Treatment. Small 2010, 6, 811–817. [Google Scholar] [CrossRef] [Green Version]
  13. Yuan, H.; Fales, A.M.; Vo-Dinh, T. TAT Peptide-Functionalized Gold Nanostars: Enhanced Intracellular Delivery and Efficient NIR Photothermal Therapy Using Ultralow Irradiance. J. Am. Chem. Soc. 2012, 134, 11358–11361. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Shi, W.; Zeng, H.; Sahoo, Y.; Ohulchanskyy, T.Y.; Ding, Y.; Wang, Z.L.; Swihart, M.; Prasad, P.N. A General Approach to Binary and Ternary Hybrid Nanocrystals. Nano Lett. 2006, 6, 875–881. [Google Scholar] [CrossRef]
  15. Li, J.; Hu, Y.; Yang, J.; Wei, P.; Sun, W.; Shen, M.; Zhang, G.; Shi, X. Hyaluronic acid-modified Fe3O4@Au core/shell nanostars for multimodal imaging and photothermal therapy of tumors. Biomaterials 2015, 38, 10–21. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, L.; Chen, Y.; Li, Z.; Li, L.; Saint-Cricq, P.; Li, C.; Lin, J.; Wang, C.; Su, Z.; Zink, J.I. Tailored Synthesis of Octopus-type Janus Nanoparticles for Synergistic Actively-Targeted and Chemo-Photothermal Therapy. Angew. Chem. Int. Ed. 2016, 55, 2118–2121. [Google Scholar] [CrossRef]
  17. Manohar, S.; Ungureanu, C.; Van Leeuwen, T.G. Gold nanorods as molecular contrast agents in photoacoustic imaging: The promises and the caveats. Contrast Media Mol. Imaging 2011, 6, 389–400. [Google Scholar] [CrossRef] [PubMed]
  18. Alkilany, A.M.; Thompson, L.B.; Boulos, S.P.; Sisco, P.N.; Murphy, C.J. Gold nanorods: Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv. Drug Deliv. Rev. 2012, 64, 190–199. [Google Scholar] [CrossRef]
  19. Zhao, P.; Liu, S.; Wang, L.; Liu, G.; Cheng, Y.; Lin, M.; Sui, K.; Zhang, H. Alginate mediated functional aggregation of gold nanoclusters for systemic photothermal therapy and efficient renal clearance. Carbohydr. Polym. 2020, 241, 116344. [Google Scholar] [CrossRef]
  20. Zhang, Y.; Chang, J.; Huang, F.; Yang, L.; Ren, C.; Ma, L.; Zhang, W.; Dong, H.; Liu, J.; Liu, J. Acid-Triggered in Situ Aggregation of Gold Nanoparticles for Multimodal Tumor Imaging and Photothermal Therapy. ACS Biomater. Sci. Eng. 2019, 5, 1589–1601. [Google Scholar] [CrossRef]
  21. Nguyen, T.T.; Mammeri, F.; Ammar, S. Iron Oxide and Gold Based Magneto-Plasmonic Nanostructures for Medical Applications: A Review. Nanomaterials 2018, 8, 149. [Google Scholar] [CrossRef] [Green Version]
  22. Tran, V.T.; Kim, J.; Tufa, L.T.; Oh, S.; Kwon, J.; Lee, J. Magnetoplasmonic Nanomaterials for Biosensing/Imaging and In Vitro/In Vivo Biousability. Anal. Chem. 2017, 90, 225–239. [Google Scholar] [CrossRef]
  23. Stafford, S.; Serrano Garcia, R.; Gun’ko, Y. Multimodal Magnetic-Plasmonic Nanoparticles for Biomedical Applications. Appl. Sci. 2018, 8, 97. [Google Scholar] [CrossRef] [Green Version]
  24. Espinosa, A.; Reguera, J.; Curcio, A.; Muñoz-Noval, Á.; Kuttner, C.; Van de Walle, A.; Liz-Marzán, L.M.; Wilhelm, C. Janus Magnetic-Plasmonic Nanoparticles for Magnetically Guided and Thermally Activated Cancer Therapy. Small 2020, 16, e1904960. [Google Scholar] [CrossRef]
  25. Multari, C.; Miola, M.; Laviano, F.; Gerbaldo, R.; Pezzotti, G.; Debellis, D.; Verné, E. Magnetoplasmonic nanoparticles for photothermal therapy. Nanotechnology 2019, 30, 255705. [Google Scholar] [CrossRef]
  26. Ohulchanskyy, T.Y.; Kopwitthaya, A.; Jeon, M.; Guo, M.; Law, W.-C.; Furlani, E.P.; Kim, C.; Prasad, P.N. Phospholipid micelle-based magneto-plasmonic nanoformulation for magnetic field-directed, imaging-guided photo-induced cancer therapy. Nanomed. Nanotechnol. Biol. Med. 2013, 9, 1192–1202. [Google Scholar] [CrossRef] [PubMed]
  27. Wu, C.-H.; Cook, J.; Emelianov, S.; Sokolov, K. Multimodal Magneto-Plasmonic Nanoclusters for Biomedical Applications. Adv. Funct. Mater. 2014, 24, 6862–6871. [Google Scholar] [CrossRef]
  28. Wheeler, D.A.; Adams, S.A.; López-Luke, T.; Torres-Castro, A.; Zhang, J.Z. Magnetic Fe3O4-Au core-shell nanostructures for surface enhanced Raman scattering. Ann. Phys. 2012, 524, 670–679. [Google Scholar] [CrossRef]
  29. Chang, S.; Yun, W.; Eichmann, S.L.; Poitzsch, M.E.; Wang, W. Magnetic SERS Composite Nanoparticles for Microfluidic Oil Reservoir Tracer Detection and Nanoprobe Applications. ACS Appl. Nano Mater. 2018, 2, 997–1004. [Google Scholar] [CrossRef]
  30. Muniz-Miranda, M.; Muniz-Miranda, F.; Giorgetti, E. Spectroscopic and Microscopic Analyses of Fe3O4/Au Nanoparticles Obtained by Laser Ablation in Water. Nanomaterials 2020, 10, 132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Reguera, J.; Jiménez de Aberasturi, D.; Winckelmans, N.; Langer, J.; Bals, S.; Liz-Marzán, L.M. Synthesis of Janus plasmonic–magnetic, star–sphere nanoparticles, and their application in SERS detection. Faraday Discuss. 2016, 191, 47–59. [Google Scholar] [CrossRef] [Green Version]
  32. Kuttner, C.; Höller, R.P.M.; Quintanilla, M.; Schnepf, M.J.; Dulle, M.; Fery, A.; Liz-Marzán, L.M. SERS and Plasmonic Heating Efficiency from Anisotropic Core/Satellite Superstructures. Nanoscale 2019, 11, 17655–17663. [Google Scholar] [CrossRef] [Green Version]
  33. Storozhuk, L.; Iukhymenko, N. Iron oxide nanoparticles modified with silanes for hyperthermia applications. App. Nanosci. 2018, 9, 889–898. [Google Scholar] [CrossRef]
  34. Briggs, M.P.; Seah, D. Practical Surface Analysis by Auger and X-ray Photoelectron Spectroscopy; John Wiley & Sons: Chichester, UK, 1983. [Google Scholar]
  35. Grotjohann, T.; Testa, I.; Reuss, M.; Brakemann, T.; Eggeling, C.; Hell, S.W.; Jakobs, S. rsEGFP2 enables fast RESOLFT nanoscopy of living cells. eLife 2012, 1, e00248. [Google Scholar] [CrossRef]
  36. Mukha, I.; Vityuk, N.; Grodzyuk, G.; Shcherbakov, S.; Lyberopoulou, A.; Efstathopoulos, E.P.; Gazouli, M. Anticancer Effect of Ag, Au, and Ag/Au Bimetallic Nanoparticles Prepared in the Presence of Tryptophan. J. Nanosci. Nanotechnol. 2017, 17, 8987–8994. [Google Scholar] [CrossRef]
  37. Mukha, I.; Khodko, A.; Vityuk, N.; Severynovska, O.; Pivovarenko, V.; Kachalova, N.; Smirnova, N.; Eremenko, A. Light-driven formation of gold/tryptophan nanoparticles. Appl. Nanosci. 2020, 10, 2827–2833. [Google Scholar] [CrossRef]
  38. Mukha, I.; Vityuk, N.; Khodko, A.; Kachalova, O.N.; Fedyshyn, O.; Malysheva, M.; Eremenko, A. Photo- and temperature-dependent formation of tryptophan/silver nanoparticles. Res. Chem. Intermed. 2019, 45, 4053–4066. [Google Scholar] [CrossRef]
  39. Sahoo, Y.; Goodarzi, A.; Swihart, M.T.; Ohulchanskyy, T.Y.; Kaur, N.; Furlani, E.P.; Prasad, P.N. Aqueous Ferrofluid of Magnetite Nanoparticles: Fluorescence Labeling and Magnetophoretic Control. J. Phys. Chem. B 2005, 109, 3879–3885. [Google Scholar] [CrossRef]
  40. Hleb, E.Y.; Hafner, J.H.; Myers, J.N.; Hanna, E.Y.; Rostro, B.C.; Zhdanok, S.A.; Lapotko, D.O. LANTCET: Elimination of solid tumor cells with photothermal bubbles generated around clusters of gold nanoparticles. Nanomedicine 2008, 3, 647–667. [Google Scholar] [CrossRef]
  41. Li, W.; Hou, W.; Guo, X.; Luo, L.; Li, Q.; Zhu, C.; Yang, J.; Zhu, J.; Du, Y.; You, J. Temperature-controlled, phase-transition ultrasound imaging-guided photothermal-chemotherapy triggered by NIR light. Theranostics 2018, 8, 3059–3073. [Google Scholar] [CrossRef]
Figure 1. Characterization of Fe3O4/Au nanocomposites prepared by chemical method. Optical absorption spectra of the initial Fe3O4/Au colloids with the different gold content (a), and their magnetic (b) and non-magnetic (c) fractions, separated by a magnet. All three samples are shown in (d): initial Fe3O4/Au colloids (I), their magnetic (II) and non-magnetic (III) fractions. TEM images of prepared samples with CAu = 2 × 10−4 M (left) and CAu = 2.5 × 10−4 M (right) are shown in (e), scale bar 100 nm.
Figure 1. Characterization of Fe3O4/Au nanocomposites prepared by chemical method. Optical absorption spectra of the initial Fe3O4/Au colloids with the different gold content (a), and their magnetic (b) and non-magnetic (c) fractions, separated by a magnet. All three samples are shown in (d): initial Fe3O4/Au colloids (I), their magnetic (II) and non-magnetic (III) fractions. TEM images of prepared samples with CAu = 2 × 10−4 M (left) and CAu = 2.5 × 10−4 M (right) are shown in (e), scale bar 100 nm.
Nanomaterials 11 01113 g001
Figure 2. XPS characterization of Fe3O4/Au nanocomposites. High-resolution O 1s XPS spectra of pure Fe3O4 NPs sample in the range of Fe 2p orbitals (a); high-resolution Fe 2p XPS spectrum of the Fe3O4/Au (CAu = 1 × 10−4 M) in comparison with the spectra of reference samples of Fe3O4, FeO, and metal Fe from the Avantage database (Thermo Scientific) (b); high-resolution XPS spectra of the series of magnetic fraction of Fe3O4/Au colloids in the range of Au 4f (c) and Fe 2p (d) peaks.
Figure 2. XPS characterization of Fe3O4/Au nanocomposites. High-resolution O 1s XPS spectra of pure Fe3O4 NPs sample in the range of Fe 2p orbitals (a); high-resolution Fe 2p XPS spectrum of the Fe3O4/Au (CAu = 1 × 10−4 M) in comparison with the spectra of reference samples of Fe3O4, FeO, and metal Fe from the Avantage database (Thermo Scientific) (b); high-resolution XPS spectra of the series of magnetic fraction of Fe3O4/Au colloids in the range of Au 4f (c) and Fe 2p (d) peaks.
Nanomaterials 11 01113 g002
Figure 3. Size assessment for Fe3O4/Au nanocomposites prepared by photochemical method. DLS size distribution by number basis of magnetic fraction of Fe3O4/Au colloids, where 1 corresponds to Fe3O4 control sample, 2 to Fe3O4/Au prepared using CAu = 1 × 10−4 M, 3—1.5 × 10−4 M, 4—2 × 10−4 M, 5—2.25 × 10−4 M, 6—CAu = 2.5 × 10−4 M (a). TEM images (scale bar 20 nm) of photochemically obtained colloids and their magnetic and non-magnetic fractions are shown in (b).
Figure 3. Size assessment for Fe3O4/Au nanocomposites prepared by photochemical method. DLS size distribution by number basis of magnetic fraction of Fe3O4/Au colloids, where 1 corresponds to Fe3O4 control sample, 2 to Fe3O4/Au prepared using CAu = 1 × 10−4 M, 3—1.5 × 10−4 M, 4—2 × 10−4 M, 5—2.25 × 10−4 M, 6—CAu = 2.5 × 10−4 M (a). TEM images (scale bar 20 nm) of photochemically obtained colloids and their magnetic and non-magnetic fractions are shown in (b).
Nanomaterials 11 01113 g003
Figure 4. Optical absorption spectra of Fe3O4/Au nanocomposites prepared by photochemical method. Absorption spectra of Fe3O4/Au colloids (a), and its magnetic fraction separated by a magnet (b).
Figure 4. Optical absorption spectra of Fe3O4/Au nanocomposites prepared by photochemical method. Absorption spectra of Fe3O4/Au colloids (a), and its magnetic fraction separated by a magnet (b).
Nanomaterials 11 01113 g004
Figure 5. Fe3O4/Au nanocomposites. Proposed structure of Fe3O4/Au nanocomposites as a core-satellites (a) and their reversible magnetic field-induced assemblies (b). (c) Illustration of the magnetophoretic effect of Fe3O4/Au nanocomposites redispersed with pluronic F68 (left cuvette) and sodium citrate (right cuvette) before and after 5 min exposure under magnet.
Figure 5. Fe3O4/Au nanocomposites. Proposed structure of Fe3O4/Au nanocomposites as a core-satellites (a) and their reversible magnetic field-induced assemblies (b). (c) Illustration of the magnetophoretic effect of Fe3O4/Au nanocomposites redispersed with pluronic F68 (left cuvette) and sodium citrate (right cuvette) before and after 5 min exposure under magnet.
Nanomaterials 11 01113 g005
Figure 6. DLS of Fe3O4/Au nanocomposites. DLS size distribution for the Fe3O4/Au nanocomposites prepared by the chemical (top) and photochemical (bottom) methods.
Figure 6. DLS of Fe3O4/Au nanocomposites. DLS size distribution for the Fe3O4/Au nanocomposites prepared by the chemical (top) and photochemical (bottom) methods.
Nanomaterials 11 01113 g006
Figure 7. Magnetic field induced changes in absorption spectra of Fe3O4/Au nanocomposites. Normalized absorbances of Fe3O4/Au nanocomposites (a) obtained by the chemical (top) and photochemical (bottom) methods before (dashed curves) and after (solid curves) magnet application; photothermal effect (temperature kinetics for the irradiated MPNC suspensions) under NIR (808 nm) laser irradiation of Fe3O4/Au nanocomposites (CAu = 2.5 × 10−4 M) (b), prepared by the chemical (top) and photochemical (bottom) methods in the presence of magnetic field (solid curves) or without it (dashed curves).
Figure 7. Magnetic field induced changes in absorption spectra of Fe3O4/Au nanocomposites. Normalized absorbances of Fe3O4/Au nanocomposites (a) obtained by the chemical (top) and photochemical (bottom) methods before (dashed curves) and after (solid curves) magnet application; photothermal effect (temperature kinetics for the irradiated MPNC suspensions) under NIR (808 nm) laser irradiation of Fe3O4/Au nanocomposites (CAu = 2.5 × 10−4 M) (b), prepared by the chemical (top) and photochemical (bottom) methods in the presence of magnetic field (solid curves) or without it (dashed curves).
Nanomaterials 11 01113 g007
Figure 8. Treatment of HeLa cells with Fe3O4/Au nanocomposites. Epifluorescence microscopy image (photo acquired through a microscope eyepiece) of HeLa cells incubated with MPNC (a); photograph of the microscope sample holder with the cell dish and magnet (b); photograph of MPNC suspension on a Petri dish exposed to magnet (c); illustration of magnetophoretic movement of MPNC revealed during 15 min (d); time series of transmission microscopy images of HeLa cells treated with Fe3O4/Au nanocomposites (e), showing movement of Fe3O4/Au nanocomposites in the magnetic field (time dependent appearance and disappearance of the aggregated MPNC in regions of interests marked as blue and green circles).
Figure 8. Treatment of HeLa cells with Fe3O4/Au nanocomposites. Epifluorescence microscopy image (photo acquired through a microscope eyepiece) of HeLa cells incubated with MPNC (a); photograph of the microscope sample holder with the cell dish and magnet (b); photograph of MPNC suspension on a Petri dish exposed to magnet (c); illustration of magnetophoretic movement of MPNC revealed during 15 min (d); time series of transmission microscopy images of HeLa cells treated with Fe3O4/Au nanocomposites (e), showing movement of Fe3O4/Au nanocomposites in the magnetic field (time dependent appearance and disappearance of the aggregated MPNC in regions of interests marked as blue and green circles).
Nanomaterials 11 01113 g008
Figure 9. Assessment of photothermal effect of Fe3O4/Au nanocomposites. Confocal microscopy images ((a,b) fluorescence, (c,d) reflection, and (e,f) transmission) of the formation of microbubbles in HeLa cells treated with Fe3O4/Au nanocomposites before (left (a,c,e)) and after (right (b,d,f)) irradiation with 593 nm laser.
Figure 9. Assessment of photothermal effect of Fe3O4/Au nanocomposites. Confocal microscopy images ((a,b) fluorescence, (c,d) reflection, and (e,f) transmission) of the formation of microbubbles in HeLa cells treated with Fe3O4/Au nanocomposites before (left (a,c,e)) and after (right (b,d,f)) irradiation with 593 nm laser.
Nanomaterials 11 01113 g009
Table 1. Atomic ratio of the elements in Fe3O4/Au.
Table 1. Atomic ratio of the elements in Fe3O4/Au.
CAu, M
in Colloid (Initial)
Au:Fe
in Colloid (Initial)
Au:Fe 2p
in Magnetic Component (XPS)
1.0 × 10−40.6670.053 (5:95)
1.5 × 10−41.0000.111 (10:90)
2.0 × 10−41.3330.333 (25:75)
2.5 × 10−41.6672.333 (70:30)
3.0 × 10−42.0002.333 (70:30)
Table 2. Optical and morphological characteristics of Fe3O4/Au nanocomposites.
Table 2. Optical and morphological characteristics of Fe3O4/Au nanocomposites.
Sampleλmax 0,
nm
λmax 1,
nm
ΔλH+,
nm
λmax 2,
nm
r 800r 900Fe3O4/Au Size,
nm (DLS)
Gold NPs Size,
nm (TEM)
t-1.5527549225491.301.35<20011.8 ± 2.5
t-2.0532552205491.221.28100–4008.9 ± 1,4
t-2.5567602356001.071.20200–500 (1000–3000)10.6 ± 2.7
UV-1.5523540175361.451.50400–10008.7 ± 1.4
UV-2.0527545185431.551.66800–150010.6 ± 2.8
UV-2.5533551185481.361.522000–40009.5 ± 2.4
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mukha, I.; Chepurna, O.; Vityuk, N.; Khodko, A.; Storozhuk, L.; Dzhagan, V.; Zahn, D.R.T.; Ntziachristos, V.; Chmyrov, A.; Ohulchanskyy, T.Y. Multifunctional Magneto-Plasmonic Fe3O4/Au Nanocomposites: Approaching Magnetophoretically-Enhanced Photothermal Therapy. Nanomaterials 2021, 11, 1113. https://doi.org/10.3390/nano11051113

AMA Style

Mukha I, Chepurna O, Vityuk N, Khodko A, Storozhuk L, Dzhagan V, Zahn DRT, Ntziachristos V, Chmyrov A, Ohulchanskyy TY. Multifunctional Magneto-Plasmonic Fe3O4/Au Nanocomposites: Approaching Magnetophoretically-Enhanced Photothermal Therapy. Nanomaterials. 2021; 11(5):1113. https://doi.org/10.3390/nano11051113

Chicago/Turabian Style

Mukha, Iuliia, Oksana Chepurna, Nadiia Vityuk, Alina Khodko, Liudmyla Storozhuk, Volodymyr Dzhagan, Dietrich R.T. Zahn, Vasilis Ntziachristos, Andriy Chmyrov, and Tymish Y. Ohulchanskyy. 2021. "Multifunctional Magneto-Plasmonic Fe3O4/Au Nanocomposites: Approaching Magnetophoretically-Enhanced Photothermal Therapy" Nanomaterials 11, no. 5: 1113. https://doi.org/10.3390/nano11051113

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop